Phase 3 Viremia Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Kidney Transplant Failure and RejectionBK ViremiaKidney Transplant Infection
The University of Queensland280 enrolled12 locationsNCT05325008
Recruiting
Phase 2Phase 3
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Heart Transplant InfectionCMV ViremiaHeart Transplant Failure and Rejection
Columbia University150 enrolled2 locationsNCT07079735